Skip to main content

Tavira Therapeutics

Teuven, Belgium

Tavira Therapeutics develops an advanced platform that enhances AAV (adeno-associated virus) gene delivery.

$357K raised
Feb 2025
Grant

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Tavira Therapeutics

How much funding has Tavira Therapeutics raised?
Tavira Therapeutics has raised $357K in total funding. The most recent round was Grant. The last funding was announced in February 2025.
Who are Tavira Therapeutics's investors?
Tavira Therapeutics's investors include Gemma Frisius Fund, General Inception, Flanders Innovation & Entrepreneurship (VLAIO).
Where is Tavira Therapeutics headquartered?
Tavira Therapeutics is headquartered in Teuven, Belgium.
What does Tavira Therapeutics do?
Tavira Therapeutics develops an advanced platform that enhances AAV (adeno-associated virus) gene delivery.
What stage is Tavira Therapeutics at?
Tavira Therapeutics is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Tavira Therapeutics — Funding & Investors." VCBacked, February 4, 2025, https://www.vcbacked.co/company/tavira-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2025). Tavira Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/tavira-therapeutics
Wikipedia (cite web)
{{cite web |title=Tavira Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tavira-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .